Skip to main content

Table 1 Characteristics of the studies included in this review

From: The optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis

Study Author, year

Timing of randomisation

ART

COH protocols

Total

Initiation of P

Dose & route of administration

No.

Early P cessation group

No.

Continuation group

Kohls, 2012

Clinical pregnancy

IVF/ICSI

GnRH-anta

220

OR

vaginal P 200mg bid

110

week 5

110

week 8

Kyrou, 2011

Positive hCG test

IVF/ICSI

GnRH-anta

200

ET

vaginal P 200mg tid

100

the 16th day post-ET

100

week 7

Goudge, 2010

COH

IVF

GnRH-a/GnRH-anta

101

ET/OR

IM P50mg qd

53

the 11th day post-ET

48

week 6

Aboulghar, 2008

Clinical pregnancy

ICSI

GnRH-a

257

Unstated

IM or vaginal P

125

week 6-7

132

week 9-10

Andersen, 2002

Positive hCG test

IVF/ICSI

GnRH-a

303

ET

vaginal P 200mg tid

150

the 14th day post-ET

153

week 7

Prietl, 1992

Positive hCG test

IVF

CC/hMG/GnRH-a

120

Unstated

PC500mg/EV10mg tiw

65

the 12th day post-ET

55

week 12